Rockefeller Capital Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,800
| Closed | -$8K | – | 2077 |
|
|
2023
Q1 | $8K | Sell |
20,800
-1,501
| -7% | -$577 | ﹤0.01% | 1962 |
|
|
2022
Q4 | $26K | Buy |
22,301
+1,500
| +7% | +$1.75K | ﹤0.01% | 2705 |
|
|
2022
Q3 | $48K | Buy |
20,801
+2,700
| +15% | +$6.23K | ﹤0.01% | 2377 |
|
|
2022
Q2 | $40K | Sell |
18,101
-2,000
| -10% | -$4.42K | ﹤0.01% | 2402 |
|
|
2022
Q1 | $193K | Sell |
20,101
-75,957
| -79% | -$729K | ﹤0.01% | 1710 |
|
|
2021
Q4 | $952K | Buy |
96,058
+21,900
| +30% | +$217K | ﹤0.01% | 1061 |
|
|
2021
Q3 | $733K | Buy |
74,158
+64,158
| +642% | +$634K | ﹤0.01% | 1118 |
|
|
2021
Q2 | $98K | Buy |
+10,000
| New | +$98K | ﹤0.01% | 1813 |
|